hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance

Barrett's esophagus (BE) is the only well-known precursor lesion of esophageal adenocarcinoma (EA). The exact estimates of the annual progression rate from BE to EA vary from 0.07% to 3.6%. The identification of BE patients at higher risk to progress to EA is hence mandatory, although difficult...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncotarget
المؤلفون الرئيسيون: Lastraioli, Elena, Lottini, Tiziano, Iorio, Jessica, Freschi, Giancarlo, Fazi, Marilena, Duranti, Claudia, Carraresi, Laura, Messerini, Luca, Taddei, Antonio, Ringressi, Maria Novella, Salemme, Marianna, Villanacci, Vincenzo, Vindigni, Carla, Tomezzoli, Anna, Mendola, Roberta La, Bencivenga, Maria, Compagnoni, Bruno, Chiudinelli, Mariella, Saragoni, Luca, Manzi, Ilaria, Manzoni, Giovanni De, Bechi, Paolo, Boni, Luca, Arcangeli, Annarosa
التنسيق: Artigo
اللغة:Inglês
منشور في: Impact Journals LLC 2016
الموضوعات:
Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312329/
https://ncbi.nlm.nih.gov/pubmed/27517748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11149
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة